These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 9815748

  • 1. K252a inhibits proliferation of glioma cells by blocking platelet-derived growth factor signal transduction.
    Chin LS, Murray SF, Zitnay KM, Rami B.
    Clin Cancer Res; 1997 May; 3(5):771-6. PubMed ID: 9815748
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of platelet-derived growth factor-mediated signal transduction and tumor growth by N-[4-(trifluoromethyl)-phenyl]5-methylisoxazole-4-carboxamide.
    Shawver LK, Schwartz DP, Mann E, Chen H, Tsai J, Chu L, Taylorson L, Longhi M, Meredith S, Germain L, Jacobs JS, Tang C, Ullrich A, Berens ME, Hersh E, McMahon G, Hirth KP, Powell TJ.
    Clin Cancer Res; 1997 Jul; 3(7):1167-77. PubMed ID: 9815796
    [Abstract] [Full Text] [Related]

  • 3. K252a is a selective inhibitor of the tyrosine protein kinase activity of the trk family of oncogenes and neurotrophin receptors.
    Tapley P, Lamballe F, Barbacid M.
    Oncogene; 1992 Feb; 7(2):371-81. PubMed ID: 1312698
    [Abstract] [Full Text] [Related]

  • 4. An abnormal response of retinoblastoma cells (Y-79) to neurotrophins.
    Wagner N, Wagner KD, Sefton M, Rodríguez-Tébar A, Grantyn R.
    Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1932-9. PubMed ID: 10845619
    [Abstract] [Full Text] [Related]

  • 5. Anti-proliferative effect of the kinase inhibitor K252a on human prostatic carcinoma cell lines.
    Delsite R, Djakiew D.
    J Androl; 1996 Jun; 17(5):481-90. PubMed ID: 8957691
    [Abstract] [Full Text] [Related]

  • 6. Blockade of the epidermal growth factor receptor tyrosine kinase activity by quercetin and luteolin leads to growth inhibition and apoptosis of pancreatic tumor cells.
    Lee LT, Huang YT, Hwang JJ, Lee PP, Ke FC, Nair MP, Kanadaswam C, Lee MT.
    Anticancer Res; 2002 Jun; 22(3):1615-27. PubMed ID: 12168845
    [Abstract] [Full Text] [Related]

  • 7. Neurotrophic factors in the human cornea.
    You L, Kruse FE, Völcker HE.
    Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):692-702. PubMed ID: 10711683
    [Abstract] [Full Text] [Related]

  • 8. Platelet-derived growth factor in human glioma.
    Westermark B, Heldin CH, Nistér M.
    Glia; 1995 Nov; 15(3):257-63. PubMed ID: 8586462
    [Abstract] [Full Text] [Related]

  • 9. Effect of exogenous neurotrophins on Trk receptor phosphorylation, cell proliferation, and neurotrophin secretion by cells isolated from the human lamina cribrosa.
    Lambert WS, Clark AF, Wordinger RJ.
    Mol Vis; 2004 Apr 19; 10():289-96. PubMed ID: 15105791
    [Abstract] [Full Text] [Related]

  • 10. Differential effect of imatinib and synergism of combination treatment with chemotherapeutic agents in malignant glioma cells.
    Ren H, Tan X, Dong Y, Giese A, Chou TC, Rainov N, Yang B.
    Basic Clin Pharmacol Toxicol; 2009 Mar 19; 104(3):241-52. PubMed ID: 19159435
    [Abstract] [Full Text] [Related]

  • 11. Autocrine regulation of nerve growth factor expression by Trk receptors.
    Mallei A, Rabin SJ, Mocchetti I.
    J Neurochem; 2004 Sep 19; 90(5):1085-93. PubMed ID: 15312164
    [Abstract] [Full Text] [Related]

  • 12. Neurotrophin receptor expression in human primary retinoblastomas and retinoblastoma cell lines.
    Stephan H, Zakrzewski JL, Bölöni R, Grasemann C, Lohmann DR, Eggert A.
    Pediatr Blood Cancer; 2008 Feb 19; 50(2):218-22. PubMed ID: 17973327
    [Abstract] [Full Text] [Related]

  • 13. The involvement of platelet-derived growth factor receptors and insulin-like growth factor-I receptors signaling during mineralized nodule formation by human periodontal ligament cells.
    Nemoto E, Shimonishi M, Nitta Y, Shimauchi H.
    J Periodontal Res; 2004 Dec 19; 39(6):388-97. PubMed ID: 15491343
    [Abstract] [Full Text] [Related]

  • 14. Coadministration of sorafenib with rottlerin potently inhibits cell proliferation and migration in human malignant glioma cells.
    Jane EP, Premkumar DR, Pollack IF.
    J Pharmacol Exp Ther; 2006 Dec 19; 319(3):1070-80. PubMed ID: 16959960
    [Abstract] [Full Text] [Related]

  • 15. Detection of NGF-receptors TrkA and p75NTR in human tumor cell lines and effect of NGF on the growth characteristic of the UT-7/EPO cell line.
    Westphal G, van den Berg-Stein S, Braun K, Knoch TA, Dümmerling M, Langowski J, Debus J, Friedrich E.
    J Exp Clin Cancer Res; 2002 Jun 19; 21(2):255-67. PubMed ID: 12148587
    [Abstract] [Full Text] [Related]

  • 16. K252a inhibits the oncogenic properties of Met, the HGF receptor.
    Morotti A, Mila S, Accornero P, Tagliabue E, Ponzetto C.
    Oncogene; 2002 Jul 25; 21(32):4885-93. PubMed ID: 12118367
    [Abstract] [Full Text] [Related]

  • 17. Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors.
    Buchdunger E, Cioffi CL, Law N, Stover D, Ohno-Jones S, Druker BJ, Lydon NB.
    J Pharmacol Exp Ther; 2000 Oct 25; 295(1):139-45. PubMed ID: 10991971
    [Abstract] [Full Text] [Related]

  • 18. NT-3-mediated TrkC receptor activation promotes proliferation and cell survival of rodent progenitor oligodendrocyte cells in vitro and in vivo.
    Kumar S, Kahn MA, Dinh L, de Vellis J.
    J Neurosci Res; 1998 Dec 15; 54(6):754-65. PubMed ID: 9856859
    [Abstract] [Full Text] [Related]

  • 19. Neurotrophin and neurotrophin receptor expression by cells of the human lamina cribrosa.
    Lambert W, Agarwal R, Howe W, Clark AF, Wordinger RJ.
    Invest Ophthalmol Vis Sci; 2001 Sep 15; 42(10):2315-23. PubMed ID: 11527945
    [Abstract] [Full Text] [Related]

  • 20. Platelet-derived growth factor (PDGF) and glial tumorigenesis.
    Shih AH, Holland EC.
    Cancer Lett; 2006 Feb 08; 232(2):139-47. PubMed ID: 16139423
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.